Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-09-16

FDA Approved: ZADITOR — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Zaditor (ketotifen fumarate) submitted by Alcon Laboratories, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZADITOR (ketotifen fumarate)

Snippet

SUPPL AP for ZADITOR (KETOTIFEN FUMARATE)